Patten Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.29M | Buy |
27,316
+49
| +0.2% | +$5.66K | 0.57% | 46 |
|
|
2025
Q4 | $2.87M | Sell |
27,267
-2,517
| -8% | -$236K | 0.53% | 49 |
|
|
2025
Q3 | $2.5M | Sell |
29,784
-1,129
| -4% | -$93K | 0.49% | 55 |
|
|
2025
Q2 | $2.45M | Buy |
30,913
+140
| +0.5% | +$11.1K | 0.52% | 51 |
|
|
2025
Q1 | $2.76M | Buy |
30,773
+396
| +1% | +$37K | 0.63% | 41 |
|
|
2024
Q4 | $3.02M | Buy |
30,377
+3,641
| +14% | +$375K | 0.67% | 37 |
|
|
2024
Q3 | $3.04M | Buy |
26,736
+1,645
| +7% | +$195K | 0.67% | 37 |
|
|
2024
Q2 | $3.11M | Buy |
25,091
+27
| +0.1% | +$3.48K | 0.73% | 32 |
|
|
2024
Q1 | $3.31M | Sell |
25,064
-119
| -0.5% | -$14.7K | 0.81% | 31 |
|
|
2023
Q4 | $2.75M | Sell |
25,183
-756
| -3% | -$78.5K | 0.75% | 36 |
|
|
2023
Q3 | $2.67M | Sell |
25,939
-275
| -1% | -$29.6K | 0.8% | 34 |
|
|
2023
Q2 | $3.02M | Hold |
26,214
| – | – | 0.45% | 26 |
|
|
2023
Q1 | $2.79M | Buy |
26,214
+731
| +3% | +$78.9K | 0.84% | 29 |
|
|
2022
Q4 | $2.83M | Buy |
25,483
+1,257
| +5% | +$128K | 0.89% | 30 |
|
|
2022
Q3 | $2.12M | Buy |
24,226
+21
| +0.1% | +$1.88K | 0.73% | 33 |
|
|
2022
Q2 | $2.25M | Sell |
24,205
-124
| -0.5% | -$11K | 0.72% | 33 |
|
|
2022
Q1 | $2M | Sell |
24,329
-150
| -0.6% | -$11.8K | 0.56% | 49 |
|
|
2021
Q4 | $1.88M | Sell |
24,479
-3,368
| -12% | -$268K | 0.5% | 57 |
|
|
2021
Q3 | $2.09M | Sell |
27,847
-2,374
| -8% | -$181K | 0.62% | 42 |
|
|
2021
Q2 | $2.35M | Sell |
30,221
-2,434
| -7% | -$181K | 0.69% | 36 |
|
|
2021
Q1 | $2.4M | Sell |
32,655
-352
| -1% | -$26K | 0.77% | 32 |
|
|
2020
Q4 | $2.58M | Buy |
33,007
+4,167
| +14% | +$319K | 0.7% | 31 |
|
|
2020
Q3 | $2.28M | Buy |
28,840
+1,362
| +5% | +$107K | 0.89% | 26 |
|
|
2020
Q2 | $2.03M | Buy |
27,478
+1,656
| +6% | +$125K | 0.87% | 25 |
|
|
2020
Q1 | $1.9M | Sell |
25,822
-788
| -3% | -$61.9K | 0.98% | 23 |
|
|
2019
Q4 | $2.31M | Buy |
26,610
+178
| +0.7% | +$14.6K | 0.86% | 29 |
|
|
2019
Q3 | $2.12M | Sell |
26,432
-205
| -0.8% | -$16.4K | 0.86% | 33 |
|
|
2019
Q2 | $2.13M | Buy |
26,637
+80
| +0.3% | +$6.13K | 0.87% | 31 |
|
|
2019
Q1 | $2.11M | Sell |
26,557
-74
| -0.3% | -$5.54K | 0.91% | 32 |
|
|
2018
Q4 | $1.94M | Buy |
26,631
+246
| +0.9% | +$17.4K | 0.92% | 30 |
|
|
2018
Q3 | $1.79M | Sell |
26,385
-847
| -3% | -$54K | 0.68% | 39 |
|
|
2018
Q2 | $1.58M | Sell |
27,232
-1,437
| -5% | -$81.1K | 0.63% | 43 |
|
|
2018
Q1 | $1.49M | Sell |
28,669
-1,358
| -5% | -$73.3K | 0.61% | 49 |
|
|
2017
Q4 | $1.61M | Sell |
30,027
-6,072
| -17% | -$337K | 0.64% | 44 |
|
|
2017
Q3 | $2.21M | Sell |
36,099
-100
| -0.3% | -$6.06K | 0.89% | 32 |
|
|
2017
Q2 | $2.18M | Buy |
36,199
+3,900
| +12% | +$237K | 0.88% | 31 |
|
|
2017
Q1 | $1.95M | Buy |
32,299
+279
| +0.9% | +$16.9K | 0.84% | 32 |
|
|
2016
Q4 | $1.89M | Sell |
32,020
-356
| -1% | -$20.8K | 0.85% | 34 |
|
|
2016
Q3 | $1.93M | Buy |
32,376
+4,947
| +18% | +$289K | 0.9% | 29 |
|
|
2016
Q2 | $1.51M | Sell |
27,429
-47
| -0.2% | -$2.5K | 0.71% | 40 |
|
|
2016
Q1 | $1.39M | Buy |
27,476
+56
| +0.2% | +$2.74K | 0.66% | 41 |
|
|
2015
Q4 | $1.38M | Buy |
27,420
+2,211
| +9% | +$111K | 0.66% | 41 |
|
|
2015
Q3 | $1.19M | Sell |
25,209
-1,410
| -5% | -$74.9K | 0.61% | 44 |
|
|
2015
Q2 | $1.45M | Buy |
26,619
+262
| +1% | +$14.7K | 0.69% | 40 |
|
|
2015
Q1 | $1.45M | Sell |
26,357
-183
| -0.7% | -$10.4K | 0.74% | 40 |
|
|
2014
Q4 | $1.44M | Buy |
+26,540
| New | +$1.48M | 0.7% | 41 |
|
Other funds holding MRK
VCM
VPM
Patten Group's MRK Position: Q1 2026 in Review
Patten Group increased its Merck (MRK) stake by 0.18% in Q1 2026, buying an estimated $5.66K and bringing the position to 27,316 shares worth $3.29M. The position accounts for 0.57% of the portfolio, ranked #46.
Patten Group first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $3.31M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Patten Group held 27,316 shares of Merck worth $3.29M as of Q1 2026.
- Patten Group bought 49 Merck shares in Q1 2026, an estimated $5.66K.
- Merck made up 0.57% of Patten Group's portfolio in Q1 2026, its #46 holding.
- Patten Group first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- Patten Group's Merck position peaked at $3.31M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Patten Group's 13F filing for Q1 2026, filed 24 Apr 2026.